Long-term endocrine effects of cancer treatment: experience of the Royal Children's Hospital, Melbourne

J Paediatr Child Health. 2005 Jan-Feb;41(1-2):36-42. doi: 10.1111/j.1440-1754.2005.00533.x.

Abstract

Objectives: To evaluate the frequency and degree of severity of endocrine late effects in patients treated for childhood cancer and to assess the value of the late effects clinic for continued monitoring of these patients.

Method: Data was collected on all patients who attended the late effects clinic at the Royal Children's Hospital (RCH) between 1998-2003. Endocrine function was assessed by clinical and biochemical evaluation at the time of presentation and at ongoing intervals of 3-12 months as clinically indicated.

Results: A total of 249 children attended the late effects clinic. Two hundred and thirty five endocrine diagnoses were made in 155 (62%) patients, of whom 63 patients had multiple endocrinopathies.

Conclusion: Our audit supports the need for ongoing prospective surveillance in survivors of childhood cancer. Appropriate and timely interventions in such patients can help to reduce morbidity and improve quality of life.

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Child
  • Endocrine System Diseases / chemically induced*
  • Endocrine System Diseases / epidemiology
  • Female
  • Follow-Up Studies
  • Humans
  • Hypothyroidism / etiology*
  • Male
  • Neoplasms* / diagnosis
  • Neoplasms* / drug therapy
  • Neoplasms* / radiotherapy
  • Pituitary Diseases / etiology*
  • Radiation Injuries / epidemiology
  • Radiation Injuries / physiopathology*
  • Victoria / epidemiology

Substances

  • Antineoplastic Agents